Gavestinel sodium

CAS No. 153436-38-5

Gavestinel sodium( —— )

Catalog No. M33855 CAS No. 153436-38-5

Gavestinel (GV 150526) is a non-competitive NMDA receptor antagonist that is potent, selective and orally active.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 85 In Stock
10MG 140 In Stock
25MG 236 In Stock
50MG 343 In Stock
100MG 505 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Gavestinel sodium
  • Note
    Research use only, not for human use.
  • Brief Description
    Gavestinel (GV 150526) is a non-competitive NMDA receptor antagonist that is potent, selective and orally active.
  • Description
    Gavestinel (GV 150526A) is a potent, selective, orally active and non-competitive antagonist of NMDA receptor. Gavestinel binds to the glycine site of the NMDA receptor, with a pKi of 8.5. Gavestinel can be used for the research of acute ischemic stroke.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    iGluR | NMDAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    153436-38-5
  • Formula Weight
    397.19
  • Molecular Formula
    C18H11Cl2N2NaO3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (251.77 mM; Ultrasonic )
  • SMILES
    O=C(NC1=CC=CC=C1)/C=C/C2=C(C([O-])=O)NC3=CC(Cl)=CC(Cl)=C23.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Fabio RD, et, al. Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site. J Med Chem. 1997 Mar 14;40(6):841-50.?
molnova catalog
related products
  • Dasolampanel

    Dasolampanel (NGX426) is an orally bioavailable, competitive antagonist of the AMPA-kainate receptors for the treatment of chronic pain conditions including neuropathic pain and migraine.

  • PF-04958242

    PF-04958242 is a novel potent, selctive, and orally-active AMPA receptor (AMPAR) positive allosteric modulator (PAM) with Ki of 170 nM, EC50 of 370 nM.

  • CGP 37849

    CGP 37849 is a competitive orally active N-methyl-D-aspartate (NMDA) receptor antagonist ((Ki = 35 nM)) with potency.CGP 37849 is an anticonvulsant in rodents and also has antidepressant and anxiolytic properties.